This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignees: Gc Cell Corporation, Mogam Institute for Biomedical Research. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 8 
1 out of 17 Years Active: 2023
Title: **Innovative Contributions of Inventor Hana Choi in Cellular Therapeutics**
Introduction
Hana Choi, an inventor based in Yongin-si, South Korea, has made significant strides in the field of biomedical research. With a patent to her name, she is recognized for her innovative methods in culturing natural killer cells, which are crucial for effective cell therapy. Her work stands at the intersection of cellular biology and therapeutic applications, emphasizing the importance of her contributions to medical science.
Latest Patents
Hana Choi holds a patent for a "Method for culturing natural killer cells using T cells." This invention outlines a groundbreaking technique that involves producing natural killer cells by utilizing CD4(+) T cells as feeder cells to culture seed cells. The method allows for the selective proliferation of natural killer cells from a minimal amount of seed cells, ensuring high killing activity. Furthermore, the ability to produce large quantities of natural killer cells that can be stored increases the potential for commercialization in cell therapeutic agents.
Career Highlights
Throughout her career, Hana Choi has played various roles in influential companies in the biotechnology sector. She has worked for GC Cell Corporation, where her expertise contributed to advancements in cancer immunotherapy. Additionally, her tenure at the Mogam Institute for Biomedical Research has further highlighted her dedication to research and innovation in cellular therapies.
Collaborations
Hana Choi has collaborated with esteemed colleagues in her field, including Bo Kyung Min and Yu Kyeong Hwang. These professional relationships have allowed for a dynamic exchange of ideas and methodologies, enhancing her research outcomes and contributing to the broader scientific community.
Conclusion
Hana Choi's innovative methods for culturing natural killer cells represent a significant advancement in cellular therapies. Her efforts are paving the way for novel treatments that leverage the body's immune system to combat diseases. As her research continues, the potential implications for commercialization in medical applications are promising, solidifying her role as a vital contributor to the biomedical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile